I am a
Home I AM A Search Login

Papers of the Week


2020 Mar 03


Int Immunopharmacol


82

Anti-neuroinflammatory effect of 3,4-dihydroxybenzaldehyde in ischemic stroke.

Authors

Li X, Xiang B, Shen T, Xiao C, Dai R, He F, Lin Q
Int Immunopharmacol. 2020 Mar 03; 82:106353.
PMID: 32143007.

Abstract

Increasing evidence from human and animal studies suggests that cerebral ischemic diseases are associated with nerve dysfunction and neuroinflammation. Therefore, alleviating neuroinflammation is a potential way to treat ischemic stroke. Gastrodia elata Blume (GEB) is a traditional Chinese medicine used to treat central nervous system diseases and related conditions, such as vertigo, headache, epilepsy. We have previously shown that GEB has a protective effect in ischemic stroke, and that the underlying mechanism is related to anti-neuroinflammation. 3,4-Dihydroxybenzaldehyde (DBD) is a phenolic component of GEB and may be responsible for the neuroprotective effect of GEB; however, the detailed molecular mechanisms underlying the effects of DBD are unknown.